Resmed RMD Institutional Ownership

Updated Oct 21, 2026

Resmed Inc (NYSE:RMD) counted 887 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• Collectively, these holders controlled 68.66% of Resmed's outstanding shares in Q2 2026, up from 66.58% in Q1 2026.
• Total shares held in Resmed rose 3.25% from Q1 2026, while the number of holders fell 3.48% from Q2 2025.
• Looking at the 887 holders of RMD individually, 404 added to their positions, 358 reduced their stakes and 125 left their positions unchanged.
• Combined, institutional investors held 99.91Mn shares of RMD as of Q2 2026, up 3.14Mn from the prior quarter and up 10.24Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Resmed was BlackRock, Inc. with 12.32Mn shares, or 8.46% of shares outstanding.
• Holders that added the most shares of Resmed in Q2 2026 were First Trust Advisors LP (+740.87K shares), Arrowstreet Capital, Limited Partnership (+679.49K shares), UBS Group AG (+562.49K shares), AQR Capital Management LLC (+560.78K shares) and Federated Hermes, Inc. (+440.46K shares).
• On the other side, among holders that kept a position in Resmed, the largest reductions in Q2 2026 came from Morgan Stanley (-757.89K shares), Bank of New York Mellon Corp (-727.78K shares), Amundi (-457.88K shares), Captrust Financial Advisors (-438.81K shares) and Marshall Wace, LLP (-374.66K shares).
• Per Business Quant data, the 10 largest holders of Resmed at the end of Q2 2026 were BlackRock, Inc. (12.32Mn shares), Vanguard Capital Management LLC (9.47Mn shares), Vanguard Portfolio Management LLC (7.91Mn shares), State Street Corp (6.68Mn shares), Geode Capital Management, LLC (4.35Mn shares), Bank of New York Mellon Corp (4.2Mn shares), First Trust Advisors LP (2.28Mn shares), Invesco Ltd. (2.06Mn shares), Morgan Stanley (1.93Mn shares) and Northern Trust Corp (1.7Mn shares).